NAVLE Gastrointestinal and Digestive

Bovine Paratuberculosis (Johne's Disease) – NAVLE Study Guide

Paratuberculosis (also known as Johne's disease, pronounced "YO-nees") is a chronic, progressive, granulomatous enteritis of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP).

Overview and Clinical Importance

Paratuberculosis (also known as Johne's disease, pronounced "YO-nees") is a chronic, progressive, granulomatous enteritis of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP). This disease represents one of the most economically significant infectious diseases affecting the global cattle industry, with annual losses estimated at $198-250 million in the United States alone.

The disease is characterized by a prolonged subclinical phase lasting 2-10 years before clinical signs appear, making early detection extremely challenging. Approximately 68% of U.S. dairy herds have at least one infected animal, with herd prevalence approaching 100% in large dairy operations.

High-YieldJohne's disease is a WOAH-listed disease requiring international reporting. Remember: chronic diarrhea + weight loss + good appetite in an adult cow (greater than 2 years) = think Johne's disease!
Parameter Dairy Cattle Beef Cattle
Herd-level prevalence 68-91% 5-10%
Within-herd prevalence 1-15% 1-5%
Large herd prevalence Approaching 100% Variable

Etiology

Mycobacterium avium subspecies paratuberculosis (MAP) is a small (0.5 x 1.5 micrometers), acid-fast, Gram-positive, obligate intracellular bacterium. MAP is closely related to Mycobacterium avium (99% genetic similarity) but is distinct from Mycobacterium bovis and Mycobacterium tuberculosis.

Key Characteristics of MAP

  • Mycobactin-dependent: Requires mycobactin (iron chelator) for growth in culture, which is produced by other mycobacteria
  • Extremely slow-growing: 8-16 weeks for primary isolation in culture
  • Highly resistant: Survives greater than 1 year in soil, water, and pasture
  • Chlorine-resistant: Standard water chlorination (0.2 mg/L) does NOT eliminate MAP
  • Heat-sensitive: Killed by pasteurization (63 degrees C for 30 min or 72 degrees C for 15 sec)
NAVLE TipMAP is the ONLY Mycobacterium species that requires mycobactin for in vitro growth. This dependency makes MAP unable to replicate outside the host, unlike M. avium which can multiply in the environment.
Stage Clinical Signs Fecal Shedding Diagnostics
Stage I (Silent) None - typically calves and young stock None or very low, intermittent Tissue culture/PCR only (not practical)
Stage II (Subclinical) None apparent - may have reduced milk production Intermittent, low numbers Fecal culture/PCR may detect 15-25%; ELISA variable
Stage III (Clinical) Chronic diarrhea, weight loss, normal appetite, decreased milk Heavy, consistent shedding (billions/day) Fecal culture/PCR greater than 90% sensitive; ELISA positive
Stage IV (Advanced) Severe emaciation, bottle jaw, profuse diarrhea, death Massive shedding All tests highly sensitive; necropsy diagnostic

Epidemiology and Transmission

Global Distribution

Johne's disease has a worldwide distribution and is endemic in most countries with intensive cattle production. Only certain states in Australia have been declared free of the disease.

Prevalence Data (NAHMS Studies)

Transmission Routes

The primary route of transmission is fecal-oral. Calves are most susceptible in the first 6 months of life, with resistance increasing with age (though never complete).

Primary Transmission Methods

  • Ingestion of contaminated colostrum or milk: MAP can be shed in milk of infected cows
  • Contaminated environment: Feces, bedding, feed, water contaminated with MAP
  • In utero transmission: Up to 25% of calves from Stage III/IV cows may be infected before birth
  • Nursing on contaminated teats: Fecal contamination of udder
  • Semen transmission: Potential but not well documented
High-YieldClinical cattle with Johne's disease shed BILLIONS of MAP organisms per day in their feces. A single gram of feces from a clinical cow contains enough MAP to infect 100+ calves!
Test Sensitivity Specificity Notes
Serum ELISA 15-75% (varies with stage) Greater than 98% Fast, inexpensive; best for clinical animals; high shedders 75%, low shedders 15%
Milk ELISA 84-93% 82-90% Convenient for dairy herds; bulk tank testing available
Fecal Culture 38-50% Approximately 100% 8-16 weeks; definitive but slow; pooling reduces cost
Fecal PCR Similar to culture Greater than 99% Rapid (1-2 days); targets IS900 element; pooling possible
AGID 25-40% 99-100% Lower sensitivity than ELISA; used for export testing

Pathogenesis

Following oral ingestion, MAP targets the M cells overlying the Peyer's patches in the terminal ileum. The bacteria are then phagocytosed by subepithelial macrophages but are able to survive and replicate within these immune cells by evading intracellular killing mechanisms.

Sequence of Events

  • Uptake: MAP crosses intestinal epithelium via M cells in Peyer's patches (primarily ileum)
  • Macrophage invasion: MAP is phagocytosed by subepithelial macrophages but evades destruction
  • Intracellular replication: MAP multiplies slowly within macrophages (doubling time approximately 22-26 hours)
  • Local spread: Infected macrophages migrate to mesenteric lymph nodes
  • Granulomatous inflammation: Host mounts cell-mediated immune response causing progressive granulomatous enteritis
  • Intestinal thickening: Infiltration of epithelioid macrophages, lymphocytes, and giant cells causes intestinal wall thickening
  • Malabsorption: Thickened intestine cannot absorb nutrients, leading to protein-losing enteropathy
  • Clinical disease: Weight loss, diarrhea, hypoproteinemia, death
NAVLE TipThe shift from cell-mediated immunity (Th1) to humoral immunity (Th2/antibody production) marks disease progression and is detectable by ELISA. By the time antibodies are detectable, the animal is usually in late-stage infection and shedding large amounts of MAP.
Condition Distinguishing Features
Salmonellosis Acute onset, fever, bloody/mucoid diarrhea, multiple animals affected simultaneously
BVD (Mucosal Disease) Oral erosions and ulcers, younger animals (6 mo - 2 yr), fever, acute course
Winter Dysentery Seasonal (winter), affects most of herd simultaneously, rapid recovery, coronavirus etiology
Intestinal Parasitism Younger animals, responds to anthelmintic treatment, fecal egg count diagnostic
Renal Amyloidosis Chronic infection history, proteinuria, edema; no diarrhea initially
Chronic Liver Disease Icterus, elevated liver enzymes, photosensitization possible
Copper Deficiency Depigmentation of hair, poor growth in calves, low serum/liver copper

Clinical Stages of Johne's Disease

Johne's disease progresses through four distinct clinical stages, often described as the "iceberg effect" where clinical cases represent only the tip of infection in a herd.

High-YieldFor every Stage IV clinical case in a herd, expect 15-25 additional infected animals in earlier stages. This is the "iceberg concept" - clinical cases are just the tip!
Loss Category Impact
Reduced milk production Accounts for 65% of total losses; greater than 700 kg/cow reduction in high-prevalence herds
Premature culling 24% of total losses; loss of genetic potential, unrealized future production
Reduced salvage value 11% of total losses; emaciated cattle may be condemned at slaughter
Reproductive losses Subclinical infection associated with reduced fertility, longer calving intervals
Annual U.S. losses $198-250 million; approximately $33 per cow in infected herds; $200+ per cow in high-prevalence herds

Clinical Signs

Clinical signs typically appear in cattle between 2-7 years of age, often following a stressful event such as calving, transportation, or nutritional stress. The classic triad includes:

Cardinal Signs

  • Chronic, intermittent to persistent diarrhea: "Pipestream" or "hose-pipe" diarrhea - watery, often without blood or mucus, no offensive odor
  • Progressive weight loss: Despite maintained or even increased appetite - classic "wasting disease"
  • Normal temperature and appetite: No fever, animal remains bright and alert initially

Additional Clinical Findings

  • Bottle jaw (intermandibular edema): Due to hypoproteinemia from protein-losing enteropathy
  • Decreased milk production: May precede clinical signs by months
  • Poor body condition: Prominent bony prominences, muscle wasting
  • Rough, dull hair coat: May be easily epilated
  • Feces-stained tail and perineum: Evidence of chronic diarrhea
  • Infertility: Subclinically infected animals may have reduced reproductive performance

Pathology

Gross Pathology

Gross lesions in cattle are primarily confined to the terminal ileum and may extend throughout the small and large intestine. Primary gross lesions are distinctive and diagnostic when present.

Key Gross Findings

  • Thickened intestinal wall: The ileum is markedly thickened, may be 3-5x normal thickness
  • Corrugated mucosa: Mucosal surface has prominent transverse folds resembling "corrugated cardboard" or "brain-like" convolutions
  • Dilated lymphatics: Serosal lymphatic vessels are prominent and tortuous (lymphangitis)
  • Enlarged mesenteric lymph nodes: Regional lymph nodes are markedly enlarged, edematous, may be pale
  • Secondary findings: Serous atrophy of fat, muscle wasting, dependent edema, ascites, hydropericardium

Histopathology

The characteristic histologic lesion is a diffuse granulomatous enteritis WITHOUT caseation or necrosis (unlike tuberculosis).

Microscopic Findings

  • Epithelioid macrophage infiltration: Massive accumulation in lamina propria and submucosa
  • Multinucleated giant cells (Langhans-type): Present in advanced lesions
  • Villous atrophy and blunting: Due to macrophage infiltration
  • Acid-fast bacilli: Abundant intracellular organisms visible with Ziehl-Neelsen stain ("multibacillary" form)
  • No caseation or mineralization: Unlike tuberculosis (important differential)
NAVLE TipJohne's disease = diffuse granulomatous enteritis WITHOUT caseation. Tuberculosis = caseating granulomas with necrosis. This is a key histopathological distinction for board exams!

Diagnosis

Diagnosis of Johne's disease is challenging, especially in subclinically infected animals. The long incubation period and variable immune response result in no single "gold standard" antemortem test. A combination of tests is often required.

Antemortem Diagnostic Tests

Test Selection Guidelines

Clinical animal with diarrhea and weight loss: ELISA or fecal PCR - both highly sensitive in clinical cases (greater than 90%)

Herd screening: Serum or milk ELISA (cost-effective) followed by fecal PCR confirmation of positives

Pre-purchase testing: Fecal PCR preferred over ELISA; test source herd status more valuable than individual testing

Definitive confirmation: Necropsy with histopathology and tissue culture or PCR

High-YieldELISA detects ANTIBODY (humoral response) which appears LATE in infection. Fecal culture/PCR detects the ORGANISM which is shed BEFORE antibodies develop. This explains why fecal tests find 2x more positives than ELISA in the same herd!

Postmortem Diagnosis

  • Gross lesions: Thickened, corrugated ileum; enlarged mesenteric lymph nodes
  • Histopathology: Diffuse granulomatous enteritis with acid-fast organisms (Ziehl-Neelsen stain)
  • Tissue culture/PCR: Confirms presence of MAP from ileum and mesenteric lymph nodes

Differential Diagnosis

When evaluating an adult cow with chronic diarrhea and weight loss, consider the following differentials:

Treatment and Prognosis

There is NO effective treatment or cure for Johne's disease. Once clinical signs appear, the disease is progressive and invariably fatal. Prognosis for clinically affected animals is grave.

Treatment Considerations

  • Antimicrobials: No practical antibiotic treatment; experimental use of isoniazid and rifampin reported but not curative; lifelong treatment required
  • Supportive care: May temporarily improve comfort but does not alter disease course
  • Culling recommendation: Clinical animals should be culled promptly to reduce environmental contamination and protect calves
NAVLE TipThe correct answer on NAVLE for "treatment of Johne's disease" is that there is NO effective treatment. Culling of clinical animals and management-based control programs are the only options.

Control and Prevention

Control of Johne's disease is based on management practices to break the transmission cycle, combined with a test-and-cull strategy to identify and remove infected animals.

Key Control Principles

1. Protect Newborn Calves

  • Remove calves from dam within 1 hour of birth
  • Feed colostrum only from test-negative cows
  • Use pasteurized milk or milk replacer (never pooled waste milk)
  • Maintain clean maternity pens separate from adult housing

2. Biosecurity and Environmental Management

  • Prevent fecal contamination of feed and water
  • Separate manure handling equipment from feed equipment
  • Do not spread manure on pastures grazed by young stock
  • Maintain closed herd or purchase from test-negative herds

3. Test and Management

  • Annual testing of all adult cattle (greater than 2 years)
  • Cull or segregate test-positive animals promptly
  • Do not retain offspring from test-positive dams
  • Repeat testing annually for 5-6 years to achieve control

Vaccination

Vaccination is NOT a primary control strategy due to significant limitations:

  • Mycopar (USA - discontinued 2019): Was the only USDA-licensed vaccine; no longer available
  • Gudair (Australia, Spain): Used in sheep/goats; reduces clinical disease but does not prevent infection or shedding
  • Major limitation: Vaccination causes animals to test positive on tuberculin skin test, interfering with TB eradication programs
High-YieldOn NAVLE, the best answer for Johne's control is MANAGEMENT-BASED (protect calves from infection, test-and-cull adults). Vaccination interferes with bovine TB testing and is NOT available in the USA.

Economic Impact

Johne's disease causes significant economic losses through multiple mechanisms:

Zoonotic Considerations

MAP has been isolated from patients with Crohn's disease (a chronic inflammatory bowel disease in humans), leading to speculation about a possible zoonotic link. However:

  • As of 2024, neither WHO nor any nation has declared Johne's disease zoonotic
  • Epidemiological studies have shown variable results
  • MAP can survive pasteurization in some studies, raising food safety concerns
  • The link between MAP and Crohn's disease remains controversial and unproven

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →